Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAC Primary Therapy in Stage III Breast Cancer
NCT00004175Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Nov 1998
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Northwestern University. Started Nov 1998; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00004175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004175.